肝细胞癌查:从目前的护理标准到未来的方向
Michael Mohnasky1, Sandra Gad2, Andrew Moon3
1University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, North Carolina.
Journal of the American College of Radiology : JACR
|March 5, 2025
概括
肝细胞癌 (HCC) 查需要改进. 新兴的成像技术和风险分层显示,有望在风险人群中检测早期肝癌,这可能会增强目前的指导方针.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 诊断放射学是指诊断放射学.
- 肝脏疾病查 肝脏疾病查
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题.
- 目前的查方法如超声波具有局限性,特别是在患有肥胖或代谢功能障碍相关的脂肪性肝病 (MASLD) 的患者中.
- 随着MASLD发病率的上升和流行性型肝炎的增加,导致了大量新的HCC病例,需要更好的风险分层.
研究的目的:
- 审查目前的肝细胞癌 (HCC) 查指南.
- 总结HCC查策略的近期发展情况.
- 突出新型成像模式作为潜在的未来查工具.
主要方法:
- 这篇叙述性综述侧重于诊断和干预放射学.
- 它审查了现有的查指南及其局限性.
- 它探讨了用于HCC检测的新兴成像技术.
主要成果:
- 目前基于超声波的HCC查存在缺陷,在特定人群中有效性较低.
- 新的成像技术,如对比增强超声波和缩短的MRI协议,显示了改善早期病变检测的潜力.
- 患有非脊髓炎性MASLD和慢性型肝炎的风险分层人群可能会确定需要查的子集.
结论:
- 现有的HCC查指南需要重新评估.
- 先进的成像技术和精细的风险分层对于改善早期检测至关重要.
- 验证这些方法的临床试验对于更新查建议至关重要.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
07:25Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
1.5K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Ultrasound II: Endoscopic Ultrasound and FibroScan
63
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
63
